AMRSQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
AMRSQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Amyris's Book Value per Share for the quarter that ended in Mar. 2023 was $-1.80.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
For the Specialty Chemicals subindustry, Amyris's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Chemicals industry and Basic Materials sector, Amyris's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Amyris's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
Amyris (OTCPK:AMRSQ) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Thank you for viewing the detailed overview of Amyris's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.
J. Scott White | director | 100 ABBOTT PARK ROAD, ABBOTT PARK IL 60064 |
Philip J. Gund | officer: Chief Restructuring Officer | C/O SUNEDISON, INC., 13736 RIVERPORT DR., MARYLAND HEIGHTS MO 63043 |
M. Freddie Reiss | director | 2951 28TH STREET, SUITE 1000, SANTA MONICA CA 90405 |
Hermanus Kieftenbeld | officer: Chief Financial Officer | 259 PROSPECT PLAINS RD., BLDG A, CRANBURY NJ 08512 |
Eduardo Alvarez | officer: Chief Operating Officer | AMYRIS, INC., 5885 HOLLIS STREET, SUITE 100, EMERYVILLE CA 94608 |
Elizabeth E. Dreyer | officer: CHIEF ACCOUNTING OFFICER | EDGEWELL PERSONAL CARE, 1350 TIMBERLAKE MANOR PARKWAY, CHESTERFIELD MO 63017 |
Frank Kung | director | C/O VIVO CAPITAL, 505, PALO ALTO CA 94301 |
Nicole Kelsey | officer: General Counsel and Secretary | AMYRIS, INC., 5885 HOLLIS STREET, SUITE 100, EMERYVILLE CA 94608 |
John Melo | director, officer: President and CEO | C/O AMYRIS, INC., 5885 HOLLIS ST., SUITE 100, EMERYVILLE CA 94608 |
Anthony Hughes | officer: Chief Accounting Officer | 5885 HOLLIS STREET, SUITE 100, EMERYVILLE CA 94608 |
Ana Dutra | director | C/O KORN/FERRY INTERNATIONAL, 1900 AVENUE OF THE STARS, SUITE 2600, LOS ANGELES CA 90067 |
James F Mccann | director | ONE OLD COUNTRY ROAD, SUITE 500, CARLE PLACE NY 11514 |
Ryan Panchadsaram | director | 5885 HOLLIS ST., SUITE 100, EMERYVILLE CA 94608 |
L John Doerr | director, 10 percent owner | C/O KLEINER PERKINS CAUFIELD & BYERS, 2750 SAND HILL ROAD, MENLO PARK CA 94025 |
Julie Washington | director | C/O JAMBA, INC., 6475 CHRISTIE AVENUE, NO. 150, EMERYVILLE CA 94608 |
From GuruFocus
By PRNewswire PRNewswire • 07-12-2022
By PRNewswire PRNewswire • 07-07-2022
By PRNewswire PRNewswire • 11-01-2022
By PRNewswire PRNewswire • 02-22-2023
By PRNewswire PRNewswire • 04-24-2023
By PRNewswire • 08-10-2023
By PRNewswire PRNewswire • 11-28-2022
By PRNewswire PRNewswire • 07-03-2022
By PRNewswire PRNewswire • 12-27-2022
By PRNewswire PRNewswire • 07-13-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.